Sign In
News Digest /
Ticker: HIMS
Ticker: HIMS
09:02am, Monday, Mar 09, 2026
Stock futures drop sharply amid Middle East tensions pushing oil above $100; Hims & Hers jumps on Novo deal; Kalshi and Polymarket eye $20B valuations; HP Enterprise earnings await.
08:54am, Monday, Mar 09, 2026
Novo Nordisk partners with Hims to offer FDA-approved Wegovy and Ozempic at self-pay prices, dropping its lawsuit amid competition with compounded drug alternatives.
07:41am, Tuesday, Feb 24, 2026
Hims & Hers' bold expansion strategy, made evident by its Super Bowl ad, sparks investor concern over potential profit setbacks amid heightened marketing spend.
09:21am, Tuesday, Jun 03, 2025
Premarket movements show Dollar General surging 10% on sales forecast, Hims & Hers up 5% from an acquisition, and Constellation Energy rising 9% following a major contract with Meta. Conversely, Bumble fell 6% post-downgrade. Stay agile in trading!
03:47am, Tuesday, Feb 25, 2025
Hims & Hers Health, Inc. (NYSE: HIMS) forecasts optimism yet sees stock decline post-earnings call. Investors remain cautious amid market volatility, overshadowing promising growth potential. Traders should watch for long-term opportunities despite short-term risks.
07:29am, Friday, Sep 27, 2024
Discover 3 fast-growing beauty stocks attracting hedge fund interest. Learn how these companies are driving innovation and gaining investor attention.